MARC record from Internet Archive

LEADER: 03580cam 2200625 a 4500
001 ocm34633739
003 OCoLC
005 20180222225806.0
008 960416s1997 ctua bf 001 0 eng
010 $a 96018530
040 $aDNLM/DLC$beng$cDLC$dNLM$dUKM$dBAKER$dBTCTA$dYDXCP$dNEG$dOCLCO$dOCLCF$dOCLCQ
015 $aGB9679693$2bnb
016 7 $a9606076$2DNLM
019 $a35831918
020 $a0838580858$q(pbk. (spiral) ;$qalk. paper)
020 $a9780838580851$q(pbk. (spiral) ;$qalk. paper)
035 $a(OCoLC)34633739$z(OCoLC)35831918
050 10 $aRJ560$b.B57 1997
060 00 $a1996 L-183
060 10 $aWS 39$bB612p 1997
082 00 $a615.5/8/083$220
100 1 $aBindler, Ruth McGillis.
245 10 $aPediatric drugs & nursing implications /$cRuth McGillis Bindler, Linda Berner Howry.
246 3 $aPediatric drugs and nursing implications
250 $a2nd ed.
260 $aStamford, Conn. :$bAppleton & Lange,$c℗♭1997.
300 $axii, 658 pages :$billustrations ;$c22 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references (pages 621-623) and index.
505 0 $apt. I. Administration of Pediatric Medications. Physiological Considerations. Developmental Considerations. Techniques of Administration -- pt. II. Pediatric Medications. Guide to Drug Reference Format. Medications. App. A-1. Schedule of Controlled Substances -- App. A-2. Conscious Sedation in Children -- App. B-1. Common Toxic Effects of Antineoplastics -- App. B-2. Antineoplastic Drug Combinations -- App. B-3. Controlling Occupational Exposure to Hazardous Drugs -- App. B-4. Reportable Events for Children on Chemotherapy -- App. C. Laxatives -- App. D-1. Classes of Antiarrhythmics -- App. D-2. Resuscitation Medications, by Weight and Age -- App. D-3. Emergency Medications, by Weight and Age -- App. E-1. Childhood Immunization Schedule -- App. E-2. Immunization Schedule for Persons 7 Years of Age and Older -- App. E-3. Immunization of Immunocompromised Infants and Children -- App. E-4. Routine Immunization of HIV-infected Children -- App. E-5. Spacing of Immune Globulin Preparations and Vaccines Containing Live Measles Virus -- App. E-6. Table of Reportable Events Following Vaccination -- App. E-7. Reporting of Events Occurring After Vaccination -- App. E-8. Vaccine Adverse Event Reporting System -- App. F. IV Drug Compatibility Chart.
650 0 $aDrugs$xAdministration.
650 0 $aPediatric pharmacology.
650 0 $aPediatric nursing.
650 12 $aDrug Therapy.
650 22 $aChild.
650 22 $aInfant.
650 22 $aPharmaceutical Preparations$xadministration & dosage.
650 7 $aDrugs$xAdministration.$2fast$0(OCoLC)fst00898763
650 7 $aPediatric nursing.$2fast$0(OCoLC)fst01056451
650 7 $aPediatric pharmacology.$2fast$0(OCoLC)fst01056473
653 0 $aChildren$aDrug therapy
655 2 $aHandbooks.
655 2 $aNurses' Instruction.
700 1 $aHowry, Linda Berner.
776 08 $iOnline version:$aBindler, Ruth McGillis.$tPediatric drugs & nursing implications.$b2nd ed.$dStamford, Conn. : Appleton & Lange, ℗♭1997$w(OCoLC)606983631
938 $aBaker & Taylor$bBKTY$c66.00$d66.00$i0838580858$n0002846682$sactive
938 $aBaker and Taylor$bBTCP$n96018530
938 $aYBP Library Services$bYANK$n824139
029 1 $aAU@$b000012284520
029 1 $aNLM$b9606076
029 1 $aYDXCP$b824139
994 $aZ0$bPMR
948 $hNO HOLDINGS IN PMR - 163 OTHER HOLDINGS